A93-86945-62121
2 vaccinations
1 coded response
1 check-in
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 362 / AL
- Registered
- 2021-08-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-23
Dose 1 — Moderna
-
2021-08-23
Dose 2 — Moderna
-
2021-08-27
Registered in v-safe
-
2021-08-27
Survey response — days 1–6 daily, dose 2MedDRA: Injection site erythema, Injection site induration, No reaction on previous exposure to drug — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · HeadacheFree text: I want to report that I with the first shot I didnt have any swelling or redness or anything. My second shot, two days later I started getting a red spot about 4 inches down from the injection site. Now on this day it has spread and it is hard.MedDRA releases: 2021-09,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-23 | Moderna | No |
| 2 | 2021-08-23 | Moderna | No |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): I want to report that I with the first shot I didnt have any swelling or redness or anything. My second shot, two days later I started getting a red spot about 4 inches down from the injection site. Now on this day it has spread and it is hard.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Injection site erythema | ✓ | · | ✓ |
| SRO | Injection site induration | ✓ | · | ✓ |
| SRO | No reaction on previous exposure to drug | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release